Arménie - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

delta pharma - desloratadine - tablets film-coated - 5mg

Malajsie - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

synerrv sdn bhd - desloratadine -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

bayer new zealand limited - desloratadine 5mg - film coated tablet - 5 mg - active: desloratadine 5mg excipient: calcium hydrogen phosphate dihydrate carnauba wax maize starch opadry blue 32b10817 opadry clear ys-1-19025-a powdered cellulose purified talc white beeswax

Jordánsko - angličtina - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - desloratadine 5 mg - 5 mg

Spojené státy - angličtina - NLM (National Library of Medicine)

rebel distributors corp - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - clarinex is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets 5 mg are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients, or to loratadine. there is no information to indicate that abuse or dependency occurs with clarinex tablets.

Spojené státy - angličtina - NLM (National Library of Medicine)

merck sharp & dohme corp. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - clarinex® is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets, reditabs, and oral solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with clarinex in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the

Filipíny - angličtina - FDA (Food And Drug Administration)

merck sharp & dohme (i.a.) llc - desloratadine - tablet - 5 mg

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - desloratadine 0,5 mg/ml - oral solution - 0,5 mg/ml - desloratadine 0.5 mg/ml - desloratadine

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - desloratadine 2,5 mg - orodispersible tablet - 2,5 mg - desloratadine 2.5 mg - desloratadine

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - desloratadine 0,5 mg/ml - oral solution - 0,5 mg/ml - desloratadine 0.5 mg/ml - desloratadine